IntoCare
IntoCare Medical is a China-based surgical device company that developed the world's first Intelligent Powered Stapling Platform with E-Stapling Technology, selling disposable and reusable powered staplers to hospital surgical departments worldwide for colorectal, thoracic, bariatric, and general procedures.
- Company typePrivate
- Founded2015
- HeadquartersSuzhou, China
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What IntoCare does
IntoCare Medical is a Chinese surgical device company founded in 2015 and headquartered in Suzhou that developed what it describes as the world's first Intelligent Powered Stapling Platform with proprietary E-Stapling Technology. The platform centers on a Universal Powered Handle (offered in both disposable and reusable variants) that connects to a full range of single-use staplers, including endoscopic linear cutting (IEC), circular (ICS/ECS), linear (ILS), and linear cutting (ILC, SLC) devices, intended to reduce instrument changes during colorectal, thoracic, bariatric, and general surgery procedures. The 2025 Phoenix Series extends the architecture with an I2C Integrated Central Powering Unit rated for at least 300 surgeries, and the company holds 545+ patents across China, the US, and the EU along with CE marking for the full platform.
The company operates a hybrid go-to-market combining enterprise field sales with an international distributor network that now spans APAC, EMEA, Latin America, North America, and Africa. Marketing is anchored on clinical evidence and surgeon education, including the POWER-UP post-market registry targeting 5,000 global patients, IntoLive surgical broadcasts, IntoWebinar programs, the ICAMP learning platform, wet lab workshops, and a steady presence at IFSO, ESCP, ESTS, and ISFGS congresses. Revenue is generated almost entirely through hardware sales of disposable staplers and reusable or single-use powered handles, with quote-based pricing to hospital systems and surgical centers.
Founder and CEO Eva Zhang leads the company, which has raised approximately $94 million cumulatively across Series B and multiple Series C rounds between 2017 and 2024, with Qiming Venture Partners as the most consistent institutional investor and Yuansheng Venture Capital and BioVenture also participating. The company has prioritized ESG positioning alongside commercial expansion, securing ISO 14001:2015 in 2023 and ISO 45001:2018 in 2025, and has won recognition including Deloitte China Rising Star (2022), WIPO Global Awards finalist (2022), and Forbes China 20 Most Promising Women in Business (2025) for its founder.
IntoCare firmographics
Firmographics- Name
- IntoCare
- Legal name
- IntoCare Medical
- Website
- https://intocare.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- IntoCare Medical is a China-based surgical device company that developed the world's first Intelligent Powered Stapling Platform with E-Stapling Technology, selling disposable and reusable powered staplers to hospital surgical departments worldwide for colorectal, thoracic, bariatric, and general procedures.
- Ownership category
- akta.pro rank
IntoCare industry classification
Industry- Product category
- Surgical Stapling Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
Keywords
Where IntoCare is headquartered
LocationHeadquarters
- HQ city
- Suzhou
- HQ country
- China
- HQ region
- Asia
Offices9 records
Markets served
IntoCare business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Surgical Stapling Devices: IntoCare generates revenue through the sale of its powered stapling platform products including disposable powered handles, endoscopic linear cutting staplers, circular staplers, and linear staplers. The Universal Powered Handle is reusable while the staplers are disposable single-use products.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
IntoCare product offering
Product offeringCore offering
IntoCare develops, manufactures, and commercializes the world's first Intelligent Powered Stapling Platform with proprietary E-Stapling Technology. The platform consists of a Universal Powered Handle (available in disposable and reusable versions) that connects to a full range of disposable staplers, including endoscopic linear cutting staplers, circular staplers, linear staplers, and linear cutting staplers, used by surgeons in colorectal, thoracic, bariatric, general, and minimally invasive procedures.
Product overview
IntoCare offers the IntoCare™ Powered Stapling Platform with E-Stapling Technology, the world's first intelligent powered stapling platform. The platform consists of a Universal Powered Handle (available in both disposable and reusable versions) designed to connect with a full range of disposable staplers including: the Disposable Powered Endoscopic Linear Cutting Stapler (IEC), Disposable Powered Circular Stapler (ICS/ECS), Disposable Powered Linear Stapler (ILS), and two variants of Disposable Powered Linear Cutting Staplers (ILC and SLC). This architecture allows surgeons to use one handle with multiple stapler types, reducing procedure times, procedural costs, and learning curves. The 2025 Phoenix Series introduced the I2C® Integrated Central powering unit, supporting reuse for at least 300 surgeries and enabling universal application across multiple surgical scenarios.
Differentiator
Problem solved
Functional benefit
Brands
- Powered Stapling Platform: World's first intelligent powered stapling platform with E-Stapling Technology for surgical procedures
- E-Stapling Technology
- ICAMP
- IntoLive
- IntoWebinar
Products and services
- IntoCare™ Powered Stapling Platform with E-Stapling Technology World's first intelligent powered stapling platform with E-Stapling Technology for surgeons performing colorectal, thoracic, bariatric, general, and minimally invasive surgeries.
- IntoCare™ Disposable Powered Handle (PHDS01A)
Quantifiable outcome
- Surgeons report completing 200+ procedures with no significant complications
- +2 more outcomes
Companies that use IntoCare
Customer profileNamed customers12 records
Segments2 records
Ideal customer profiles2 records
IntoCare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
IntoCare partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered notable, core and regional.
- University Hospital Ostrava (Czech Republic)notableCentre for Robotic Surgery used IntoCare's Intelligent Powered Stapling Platform for first time in Czech Republic. Dr. Lubomír Martínek led the surgical team performing colorectal surgery.
- ISFGS (International Society of Fluorescence Guided Surgery)coreCorporate Sponsor for ISFGS EU CHAPTER 2021. Prof. Luigi Boni performed live Laparoscopic Colorectal Resection using IntoCare's powered staplers at ISFGS conference.
- AspironiX (Czech Republic)regionalCzech-Slovak distributor partner. IntoCare made first public appearance at Czech-Slovak congress of Petřivalský Rapant's Days in Olomouc with AspironiX.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
IntoCare competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic (via the former Covidien portfolio) is the other half of the global surgical stapling duopoly, offering Signia and Endo GIA stapling systems. Comparable to IntoCare as a direct competitor targeting the same surgical specialties with powered and manual stapling devices.
- Stryker: Stryker is a broad incumbent in surgical devices, with a surgical instruments and endoscopy portfolio that overlaps with IntoCare's procedural use cases (colorectal, bariatric, thoracic). Comparable as a larger, established player whose OR and surgical consumables businesses compete for the same hospital budgets.
- Ethicon (Johnson & Johnson): Ethicon is the global market leader in surgical stapling (ECHELON, ENSEAL product lines) and is the dominant incumbent IntoCare explicitly positions itself against. Same product category, same hospital customer base, and overlapping surgical use cases make it the most relevant comparable peer.
Direct peers
- Teleflex: Teleflex offers a portfolio of surgical stapling and ligation devices (e.g., Weck, Pilling brands) sold into hospital surgical departments. It competes with IntoCare in similar surgical use cases and is a publicly traded comparable for capital-markets benchmarking.
- CONMED: CONMED manufactures and sells surgical stapling and other general surgery devices to hospitals and ambulatory surgery centers. It is a directly comparable peer in terms of product category, end customers, and commercial model.
- B. Braun: B. Braun is a significant player in surgical stapling and other OR consumables, with a comparable focus on hospitals and surgical centers globally. It is a more direct peer than J&J/Medtronic in terms of scale, often competing for the same mid-tier accounts that IntoCare targets.
- Frankenman International: Frankenman International is a China- and Hong Kong-headquartered surgical stapler manufacturer (acquired by Hillrom/Baxter) and is one of the closest direct competitors to IntoCare in origin, product category, and target market. It provides a useful benchmark for Chinese stapler players scaling internationally.
Emerging players
- Grena: Grena is a UK-based emerging surgical device company focused on advanced surgical stapling technologies, comparable to IntoCare as a smaller innovator pushing novel powered and articulating stapling designs. Useful as a peer for technology benchmarking and EU market access.
- Intuitive Surgical: Intuitive Surgical (da Vinci) is an adjacent emerging player in minimally invasive and robotic-assisted surgery, where IntoCare's powered stapling platform is also used. The two companies increasingly co-market stapling consumables with robotic platforms, making them partial competitors and ecosystem partners.
- Meril Life Sciences: Meril Life Sciences (India) is an emerging surgical device company with stapling and energy products targeting emerging markets. It is a relevant peer for IntoCare as a non-incumbent challenger pursuing geographic expansion in price-sensitive markets outside the J&J/Medtronic core.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
IntoCare social profiles
Digital presenceIntoCare compliance and trust
Trust signalCompliance3 records
IntoCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
IntoCare leadership team
Management profileNumber of profiles
Profiles1 record
IntoCare funding detail
Funding detailFunding overview
Funding rounds7 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IntoCare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IntoCare
What does IntoCare do?
IntoCare develops, manufactures, and commercializes the world's first Intelligent Powered Stapling Platform with proprietary E-Stapling Technology. The platform consists of a Universal Powered Handle (available in disposable and reusable versions) that connects to a full range of disposable staplers, including endoscopic linear cutting staplers, circular staplers, linear staplers, and linear cutting staplers, used by surgeons in colorectal, thoracic, bariatric, general, and minimally invasive procedures.
Is IntoCare a public or private company?
IntoCare is a private company. It is classified as venture growth investor backed and is currently operating.
When was IntoCare founded?
IntoCare was founded in 2015. It employs 51 to 100 people.
Where is IntoCare based?
IntoCare is headquartered in Suzhou, China, in the Asia region.
How does IntoCare make money?
One revenue line is on record: surgical Stapling Devices.
Who are IntoCare's main competitors?
Broad incumbents on record are Medtronic, Stryker and Ethicon (Johnson & Johnson). Direct peers are Teleflex, CONMED, B. Braun and Frankenman International. Emerging players are Grena, Intuitive Surgical and Meril Life Sciences.
Does IntoCare have an API?
No public API is recorded for IntoCare.
What industry is IntoCare in?
IntoCare's product category is Surgical Stapling Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3841.